JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and value

Authors:

Abstract
DISCLOSURES: Funding for this summary was contributed by Arnold Ventures, The Donaghue Foundation, Harvard Pilgrim Health Care, and Kaiser Foundation Health Plan to the Institute for Clinical and E...

This publication has 32 references indexed in Scilit: